Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-49,800
Closed -$2.97M 740
2025
Q2
$2.97M Buy
+49,800
New +$2.78M 0.11% 121
2025
Q1
Sell
-2,100
Closed -$130K 133
2024
Q4
$130K Buy
+2,100
New +$137K 0.01% 126
2024
Q3
Sell
-93,400
Closed -$4.77M 135
2024
Q2
$4.77M Buy
+93,400
New +$4.77M 0.39% 83
2023
Q4
Sell
-67,521
Closed -$2.81M 423
2023
Q3
$2.81M Buy
+67,521
New +$3.2M 0.17% 79
2023
Q1
Sell
-100,197
Closed -$6.7M 58
2022
Q4
$6.7M Sell
100,197
-7,600
-7% -$526K 1.69% 27
2022
Q3
$7.66M Sell
107,797
-135,003
-56% -$10.6M 1.17% 19
2022
Q2
$17.8M Buy
242,800
+81,326
+50% +$6.57M 3.77% 9
2022
Q1
$14.6M Buy
161,474
+31,774
+24% +$3M 2.5% 7
2021
Q4
$11.3M Buy
+129,700
New +$11.1M 5.16% 4

Other funds holding CMA

Point72 Europe's CMA Position: Q3 2025 in Review

Point72 Europe sold out of Comerica (CMA) in Q3 2025, closing a stake of 49,800 shares — an estimated $2.97M sold.

Point72 Europe first reported a position in CMA in Q4 2021 and held it in 9 quarters. The position peaked at $17.8M in Q2 2022. 533 funds tracked by Wall St. Rank hold CMA as of Q3 2025.

  • Point72 Europe reported no remaining Comerica position as of Q3 2025 after selling out during the quarter.
  • Point72 Europe sold 49,800 Comerica shares in Q3 2025, an estimated $2.97M.
  • Point72 Europe first reported a position in Comerica in Q4 2021 and held it in 9 quarters.
  • Point72 Europe's Comerica position peaked at $17.8M in Q2 2022.
  • 533 funds tracked by Wall St. Rank held Comerica as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.